PMID- 33862112 OWN - NLM STAT- MEDLINE DCOM- 20210706 LR - 20230410 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 278 DP - 2021 Aug 1 TI - Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-3p targets SOCS1 to facilitate progression of esophageal cancer. PG - 119491 LID - S0024-3205(21)00476-8 [pii] LID - 10.1016/j.lfs.2021.119491 [doi] AB - OBJECTIVE: Exosomes can convey particular microRNAs (miRNAs) to affect biological functions of cancer cells. Nevertheless, the impact of bone marrow mesenchymal stem cells (BMSCs)-derived exosomes (BMSC-exos) transmitting miR-19b-3p on esophageal cancer (EC) progression remains scarcely studied. We aimed to explore the role of BMSC-exos mediating miR-19b-3p in EC cell growth. METHODS: Eighty-three cases of EC patients were included in this study and the expression of miR-19b-3p and suppressor of cytokine signaling 1 (SOCS1) in cancer and adjacent normal tissues from the patients were assessed. BMSCs were cultured and BMSC-exos were extracted, which were then transfected with altered miR-19b-3p and SOCS1 to assess their roles in proliferation, migration, invasion, epithelial-mesenchymal transition (EMT) and apoptosis of EC cells. Targeting relationship between miR-19b-3p and SOCS1 was verified by Targetscan and dual luciferase reporter gene assay. MiR-19b-3p and SOCS1 expression was assessed in TE-2 cells. RESULTS: MiR-19b-3p was upregulated and SOCS1 was downregulated in EC tissues. BMSC-exos or exosomal miR-19b-3p promoted malignant behaviors of EC cells. MiR-19b-3p was upregulated and targeted SOCS1 in EC cells. MiR-19b-3p inhibition or SOCS1 overexpression suppressed proliferation, migration, invasion and EMT, and induced apoptosis of EC cells. SOCS1 silencing abrogated these effect of miR-19b-3p inhibition on EC cells. CONCLUSION: BMSC-derived exosomal miR-19b-3p promotes progression of EC through targeting SOCS1. This study provides a novel understanding on molecular mechanisms of EC. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Deng, Yanchao AU - Deng Y AD - Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China. Electronic address: Dengyanchao123@outlook.com. FAU - Julaiti, Ainiwaer AU - Julaiti A AD - Department of Thoracic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China. FAU - Ran, Wei AU - Ran W AD - The First Clinical Medicine College of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China. FAU - He, Yao AU - He Y AD - The First Clinical Medicine College of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China. LA - eng PT - Journal Article PT - Retracted Publication DEP - 20210413 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (MIRN19 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (SOCS1 protein, human) RN - 0 (Suppressor of Cytokine Signaling 1 Protein) SB - IM RIN - Life Sci. 2023 May 15;321:121602. PMID: 36990908 MH - Apoptosis MH - Bone Marrow Cells/*metabolism MH - Cell Line MH - Cell Movement MH - Cell Proliferation MH - Disease Progression MH - Epithelial-Mesenchymal Transition MH - Esophageal Neoplasms/*metabolism MH - Exosomes/metabolism MH - Gene Expression Profiling MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Mesenchymal Stem Cells/*metabolism MH - MicroRNAs/*metabolism MH - Neoplasm Invasiveness MH - Suppressor of Cytokine Signaling 1 Protein/*metabolism OTO - NOTNLM OT - Apoptosis OT - Bone marrow mesenchymal stem cells-derived exosome OT - Esophageal cancer OT - MicroRNA-19b-3p OT - Proliferation OT - Suppressor of cytokine signaling 1 EDAT- 2021/04/17 06:00 MHDA- 2021/07/07 06:00 CRDT- 2021/04/16 20:12 PHST- 2020/09/22 00:00 [received] PHST- 2021/04/06 00:00 [revised] PHST- 2021/04/09 00:00 [accepted] PHST- 2021/04/17 06:00 [pubmed] PHST- 2021/07/07 06:00 [medline] PHST- 2021/04/16 20:12 [entrez] AID - S0024-3205(21)00476-8 [pii] AID - 10.1016/j.lfs.2021.119491 [doi] PST - ppublish SO - Life Sci. 2021 Aug 1;278:119491. doi: 10.1016/j.lfs.2021.119491. Epub 2021 Apr 13.